Holen Sie sich die Stockscreener-App
10.60
0.25%
-0.0262
Handel nachbörslich:
10.60
Schlusskurs vom Vortag:
$10.63
Offen:
$10.6
24-Stunden-Volumen:
2,127
Relative Volume:
0.14
Marktkapitalisierung:
$7.08M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-18.82M
KGV:
-0.3399
EPS:
-31.1883
Netto-Cashflow:
$-14.79M
1W Leistung:
+2.02%
1M Leistung:
-1.03%
6M Leistung:
-11.15%
1J Leistung:
-93.43%
1-Tages-Spanne:
$10.60
$10.60
1-Wochen-Bereich:
$9.85
$10.80
52-Wochen-Spanne:
$8.67
$179.55
Envveno Medical Corp Stock (NVNO) Company Profile
Firmenname
Envveno Medical Corp
Sektor
Branche
Telefon
949-261-2900
Adresse
70 DOPPLER, IRVINE
Compare NVNO vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corp
|
10.60 | 7.12M | 0 | -18.82M | -14.79M | -31.19 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Envveno Medical Corp Aktie (NVNO) Neueste Nachrichten
enVVeno Medical Corp (NVNO) Cash Flow - TradingKey
enVVeno Medical Corp (NVNO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
enVVeno Medical Corporation Revenue Breakdown – LS:A42085 - TradingView
enVVeno Medical Corp (NVNO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
enVVeno Medical Corp (NVNO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
enVVeno Medical Corp (NVNO) Income Statement - TradingKey
NVNO|enVVeno Medical Corp|Price:10.390|Chg%:+0.160 - TradingKey
NVNO|enVVeno Medical Corp|Price:10.320|Chg%:-0.070 - TradingKey
enVVeno Medical Corp (NVNO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NVNO Q3 2025 Earnings: Narrowing Losses Signal Cost DisciplineEarnings Expansion Phase - dars.gov.et
enVVeno Medical (NVNO) Surges 5% as Volume Spikes – Key Levels to WatchZigzag Correction - dars.gov.et
NVNO Q3 2025 Earnings: Narrower Loss Surprises as Company Advances Venous Therapy PipelineProfit Guidance Range - dars.gov.et
NVNO Q3 2025 Earnings: Smaller-Than-Expected Loss Signals Cost DisciplineEarnings Manipulation Risk - dars.gov.et
EnVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor What This Means Segment - marketscreener.com
enVVeno Medical Updates Investors With New Presentation - The Globe and Mail
enVVeno Medical highlights newly issued U.S. patent - TipRanks
enVVeno Medical (NVNO) Secures U.S. Patent and Advances FDA Tria - GuruFocus
enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment - ACCESS Newswire
enVVeno's non-surgical valve trial gets first-ever FDA IDE approval - Stock Titan
enVVeno Medical (NASDAQ: NVNO) releases updated investor presentation - Stock Titan
Price to earnings forward of enVVeno Medical Corporation – BOATS:NVNO - TradingView
NVNO Forecast — Price Target — Prediction for 2027 - TradingView
A42085 Forecast — Price Target — Prediction for 2027 - TradingView
enVVeno Medical receives U.S. patent for venous valve system By Investing.com - Investing.com Nigeria
enVVeno Medical receives U.S. patent for venous valve system - Investing.com
enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial - ACCESS Newswire
enVVeno patent covers key enVVe valve parts before pivotal FDA trial - Stock Titan
enVVeno Medical (NVNO) Gains 2.6% as Shares Test Key Resistance Near $11.67Ascending Triangle - dars.gov.et
NVNO Q3 2025 Earnings: Narrowing Losses Underpin Optimism as Clinical Progress ContinuesMid-Term Outlook - dars.gov.et
NVNO Q3 2025 Earnings: Narrower-than-Expected Loss Highlights Cost DisciplineTech Earnings Analysis - dars.gov.et
Enterprise value to revenue forward of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
Price to sales forward of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
Price to sales forward of enVVeno Medical Corporation – FWB:5HJ0 - TradingView
Price to book forward of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
Price to earnings forward of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
Enterprise value to EBITDA forward of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
Price to book forward of enVVeno Medical Corporation – FWB:5HJ0 - TradingView
enVVeno Medical Corporation Actuals & Estimates (FWB:5HJ0) - TradingView
enVVeno Medical Corporation Actuals & Estimates (NASDAQ:NVNO) - TradingView
enVVeno Medical Corporation Actuals & Estimates (BOATS:NVNO) - TradingView
enVVeno Medical Corp (NVNO) Institutional Confidence - TradingKey
enVVeno Medical to Present in the Webull Corporate Connect Webinar Series - ACCESS Newswire
FDA-cleared venous valve study takes center stage at enVVeno webinar - Stock Titan
enVVeno Medical (NVNO) Dips 1.96%, Testing Support at $9.5Strong Buy Stocks - dars.gov.et
enVVeno Medical Corp (NVNO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
enVVeno Medical Corp (NVNO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
enVVeno Medical Corp (NVNO) Valuation: PE, PB & Fair Value Analysis - TradingKey
enVVeno Medical Corp (NVNO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
enVVeno Medical (NVNO) Retreats 1.96% as Stock Navigates Key Support at $9.50Value Stock Ideas - newsline.com
Insider Selling: Francis Duhay Sells Shares of enVVeno Medical C - GuruFocus
Director at enVVeno Medical (NASDAQ: NVNO) sells 140 shares under Rule 10b5-1 plan - Stock Titan
Finanzdaten der Envveno Medical Corp-Aktie (NVNO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):